Impaired functioning of immune defenses to infection in premature and term infants and their implications for

David Baxter1

  • 1Clinical Epidemiology and Public Health Unit, School of Translational Medicine, Manchester University Medical School, Manchester, UK. baxter@nhs.net

Human Vaccines
|June 4, 2010
PubMed

Insights

Newborn infants, especially premature ones, face higher infection risks, impacting vaccine effectiveness. This review examines immune system differences in infants versus adults to improve infant immunization strategies.

Area of Science:

  • Immunology
  • Neonatal Health
  • Vaccinology

Background:

  • Premature and term infants exhibit increased susceptibility to infections, including vaccine-preventable diseases.
  • Immune system immaturity in newborns contributes to higher morbidity and mortality risks.
  • Infant immune responses to pathogens and vaccines can range from non-responsiveness to adult-equivalent function.

Purpose of the Study:

  • To review qualitative and quantitative differences in immune defenses between premature/term infants and adults.
  • To evaluate the implications of these immune differences for immunization outcomes in infants.
  • To inform strategies for optimizing infant vaccination schedules and efficacy.

Main Methods:

  • Literature review of studies comparing infant and adult immune systems.
  • Analysis of data on immune response variability based on host and vaccine characteristics.
  • Synthesis of evidence regarding immune defense mechanisms in neonates.

Main Results:

  • Infants possess distinct immune defense profiles compared to adults, affecting vaccine responses.
  • Immune system development is a critical factor influencing the efficacy of infant immunizations.
  • Variability in immune maturation necessitates tailored approaches to infant vaccination.

Conclusions:

  • Understanding infant immune system differences is crucial for enhancing vaccine efficacy and reducing infection-related mortality.
  • Optimizing immunization strategies requires consideration of the unique immunological landscape of newborns.
  • Further research into neonatal immunology can lead to improved public health outcomes through better vaccination protocols.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...